Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg.
11thย November 2024, Bengaluru:ย Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...